| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Acid production in glycolysis-impaired tumors provides new insights into tumor metabolism. | Clin Cancer Res | 2002 | 2.29 |
| 2 | Combined therapy with direct and indirect angiogenesis inhibition results in enhanced antiangiogenic and antitumor effects. | Cancer Res | 2003 | 1.35 |
| 3 | The selective Cox-2 inhibitor Celecoxib suppresses angiogenesis and growth of secondary bone tumors: an intravital microscopy study in mice. | BMC Cancer | 2006 | 0.97 |
| 4 | Tyrosine kinase inhibitor SU6668 represses chondrosarcoma growth via antiangiogenesis in vivo. | BMC Cancer | 2007 | 0.92 |
| 5 | Celecoxib enhances radiation response of secondary bone tumors of a human non-small cell lung cancer via antiangiogenesis in vivo. | Strahlenther Onkol | 2010 | 0.79 |